These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 29394869
1. Analgesic efficacy and safety of non-prescription doses of naproxen sodium in the management of moderate osteoarthritis of the knee or hip. Couto A, Troullos E, Moon J, Paredes-Diaz A, An R. Curr Med Res Opin; 2018 Oct; 34(10):1747-1753. PubMed ID: 29394869 [Abstract] [Full Text] [Related]
2. Comparison of the analgesic efficacy and safety of nonprescription doses of naproxen sodium and Ibuprofen in the treatment of osteoarthritis of the knee. Schiff M, Minic M. J Rheumatol; 2004 Jul; 31(7):1373-83. PubMed ID: 15229960 [Abstract] [Full Text] [Related]
3. Analgesic efficacy and safety of nonprescription doses of naproxen sodium compared with acetaminophen in the treatment of osteoarthritis of the knee. Golden HE, Moskowitz RW, Minic M. Am J Ther; 2004 Jul; 11(2):85-94. PubMed ID: 14999359 [Abstract] [Full Text] [Related]
4. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis. Temple AR, Benson GD, Zinsenheim JR, Schweinle JE. Clin Ther; 2006 Feb; 28(2):222-35. PubMed ID: 16678643 [Abstract] [Full Text] [Related]
5. A randomized, double-blind, multicenter trial of nimesulide-beta-cyclodextrin versus naproxen in patients with osteoarthritis. Fioravanti A, Storri L, Di Martino S, Bisogno S, Oldani V, Scotti A, Marcolongo R. Clin Ther; 2002 Apr; 24(4):504-19. PubMed ID: 12017396 [Abstract] [Full Text] [Related]
6. A randomized study to evaluate the analgesic efficacy of a single dose of the TRPV1 antagonist mavatrep in patients with osteoarthritis. Mayorga AJ, Flores CM, Trudeau JJ, Moyer JA, Shalayda K, Dale M, Frustaci ME, Katz N, Manitpisitkul P, Treister R, Ratcliffe S, Romano G. Scand J Pain; 2017 Oct; 17():134-143. PubMed ID: 28850367 [Abstract] [Full Text] [Related]
7. Efficacy and safety of naproxcinod in the treatment of patients with osteoarthritis of the knee: a 13-week prospective, randomized, multicenter study. Schnitzer TJ, Kivitz A, Frayssinet H, Duquesroix B. Osteoarthritis Cartilage; 2010 May; 18(5):629-39. PubMed ID: 20202489 [Abstract] [Full Text] [Related]
8. Tropomyosin-related kinase A (TrkA) inhibition for the treatment of painful knee osteoarthritis: results from a randomized controlled phase 2a trial. Watt FE, Blauwet MB, Fakhoury A, Jacobs H, Smulders R, Lane NE. Osteoarthritis Cartilage; 2019 Nov; 27(11):1590-1598. PubMed ID: 31356878 [Abstract] [Full Text] [Related]
9. Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain. Schnitzer TJ, Ekman EF, Spierings EL, Greenberg HS, Smith MD, Brown MT, West CR, Verburg KM. Ann Rheum Dis; 2015 Jun; 74(6):1202-11. PubMed ID: 24625625 [Abstract] [Full Text] [Related]
10. Comparison of the analgesic efficacy of rofecoxib and enteric-coated diclofenac sodium in the treatment of postoperative dental pain: a randomized, placebo-controlled clinical trial. Chang DJ, Desjardins PJ, Chen E, Polis AB, McAvoy M, Mockoviak SH, Geba GP. Clin Ther; 2002 Apr; 24(4):490-503. PubMed ID: 12017395 [Abstract] [Full Text] [Related]
11. Significant, long-lasting pain relief in primary dysmenorrhea with low-dose naproxen sodium compared with acetaminophen: a double-blind, randomized, single-dose, crossover study. Daniels SE, Paredes-Diaz A, An R, Centofanti R, Tajaddini A. Curr Med Res Opin; 2019 Dec; 35(12):2139-2147. PubMed ID: 31397597 [Abstract] [Full Text] [Related]
13. RETRACTED: Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. da Costa BR, Reichenbach S, Keller N, Nartey L, Wandel S, Jüni P, Trelle S. Lancet; 2016 May 21; 387(10033):2093-2105. PubMed ID: 26997557 [Abstract] [Full Text] [Related]
14. Efficacy and safety of intravenous tanezumab for the symptomatic treatment of osteoarthritis: 2 randomized controlled trials versus naproxen. Ekman EF, Gimbel JS, Bello AE, Smith MD, Keller DS, Annis KM, Brown MT, West CR, Verburg KM. J Rheumatol; 2014 Nov 21; 41(11):2249-59. PubMed ID: 25274899 [Abstract] [Full Text] [Related]
15. Onset and durability of pain relief in knee osteoarthritis: Pooled results from two placebo trials of naproxen/esomeprazole combination and celecoxib. Holt RJ, Fort JG, Grahn AY, Kent JD, Bello AE. Phys Sportsmed; 2015 Jul 21; 43(3):200-12. PubMed ID: 26313454 [Abstract] [Full Text] [Related]
16. Aceclofenac is a well-tolerated alternative to naproxen in the treatment of osteoarthritis. Kornasoff D, Frerick H, Bowdler J, Montull E. Clin Rheumatol; 1997 Jan 21; 16(1):32-8. PubMed ID: 9132323 [Abstract] [Full Text] [Related]
17. Tramadol allows reduction of naproxen dose among patients with naproxen-responsive osteoarthritis pain: a randomized, double-blind, placebo-controlled study. Schnitzer TJ, Kamin M, Olson WH. Arthritis Rheum; 1999 Jul 21; 42(7):1370-7. PubMed ID: 10403264 [Abstract] [Full Text] [Related]
18. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies. Daniels S, Robbins J, West CR, Nemeth MA. Clin Ther; 2009 Jun 21; 31(6):1192-208. PubMed ID: 19695387 [Abstract] [Full Text] [Related]